GLPwatch
Managing Adverse Effects of Incretin-Based Medications for Obesity.
JAMA · 2025
Last updated 2026-05-28| Journal | JAMA, 2025 |
|---|---|
| Citations | 13 |
| Relative citation ratio | 4.47 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 40728833 ↗
JAMA · 2025
Last updated 2026-05-28| Journal | JAMA, 2025 |
|---|---|
| Citations | 13 |
| Relative citation ratio | 4.47 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 40728833 ↗